Collegium Pharmaceutical
COLL
#6625
Rank
A$1.17 B
Marketcap
A$37.83
Share price
-2.78%
Change (1 day)
-44.79%
Change (1 year)

Earnings for Collegium Pharmaceutical (COLL)

Earnings in 2026 (TTM): A$0.17 Billion

According to Collegium Pharmaceutical 's latest financial reports the company's current earnings are A$0.81 Billion. In 2025 the company made an earning of A$0.26 Billion, an increase over its 2024 earnings that were of A$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Collegium Pharmaceutical from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.17 B-33.8%
2025 A$0.26 B1.38%
2024 A$0.25 B8.47%
2023 A$0.23 B362.88%
2022 A$51.56 M94.82%
2021 A$26.47 M-68.76%
2020 A$84.72 M-358.85%
2019 -A$32.74 Million14.82%
2018 -A$28.51 Million-74.68%
2017 -A$0.12 Billion-20.23%
2016 -A$0.15 Billion250.85%
2015 -A$40.24 Million51.81%
2014 -A$26.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
United Therapeutics
UTHR
A$2.28 B 1,179.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-A$22.55 Million-112.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
A$0.76 B 331.56%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
KemPharm
KMPH
-A$62.88 Million-135.28%๐Ÿ‡บ๐Ÿ‡ธ USA